DCM
AERI

Dupont Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

Dupont Capital Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14,422
Closed -$349K – 1404
2019
Q4 		$349K Hold
14,422
– – 0.01% 1015
2019
Q3 		$277K Sell
14,422
-3,423
-19% -$78.4K 0.01% 1030
2019
Q2 		$527K Buy
17,845
+3,048
+21% +$117K 0.01% 760
2019
Q1 		$703K Buy
+14,797
New +$651K 0.02% 643

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Dupont Capital Management's AERI Position: Q1 2020 in Review

Dupont Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q1 2020, closing a stake of 14,422 shares — an estimated $349K sold.

Dupont Capital Management first reported a position in AERI in Q1 2019 and held it in 4 quarters. The position peaked at $703K in Q1 2019. 155 funds tracked by Wall St. Rank hold AERI as of Q1 2020.

  • Dupont Capital Management reported no remaining Aerie Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Dupont Capital Management sold 14,422 Aerie Pharmaceuticals shares in Q1 2020, an estimated $349K.
  • Dupont Capital Management first reported a position in Aerie Pharmaceuticals in Q1 2019 and held it in 4 quarters.
  • Dupont Capital Management's Aerie Pharmaceuticals position peaked at $703K in Q1 2019.
  • 155 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2020.

Based on Dupont Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.